Dr. Reddy's Laboratories Limited (RDY)

NYSE: RDY · Real-Time Price · USD

14.38

+0.39 (2.79%)

At close: Jul 2, 2026, 4:00 PM EDT

14.39

+0.01 (0.07%)

After-hours: Jul 2, 2026, 7:00 PM EDT

Dr. Reddy's Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	42,466	57,245	55,684	45,067	23,568
Depreciation & Amortization	20,605	17,058	14,841	12,636	11,824
Stock-Based Compensation	326	424	407	397	592
Other Adjustments	18,520	21,683	14,730	19,344	18,059
Change in Receivables	-6,722	-10,283	-8,054	-5,752	-17,012
Changes in Inventories	-8,601	-12,753	-18,445	-2,654	-9,912
Changes in Accounts Payable	2,790	340	3,460	23	4,412
Changes in Other Operating Activities	-12,629	-27,286	-17,190	-10,186	-3,423
Operating Cash Flow	56,755	46,428	45,433	58,875	28,108
Operating Cash Flow Growth	22.24%	2.19%	-22.83%	109.46%	-21.27%
Capital Expenditures	-23,326	-27,504	-16,403	-11,323	-14,660
Sale of Property, Plant & Equipment	309	512	1,064	82	370
Purchases of Intangible Assets	-15,099	-6,894	-11,032	-7,543	-4,389
Proceeds from Sale of Intangible Assets	1,401	732	21	-	2,946
Purchases of Investments	-46,769	-28,809	-41,660	-136,171	-88,972
Proceeds from Sale of Investments	19,602	53,610	25,944	112,805	77,771
Payments for Business Acquisitions	-3,152	-53,096	-	-	-326
Other Investing Activities	1,521	3,372	1,783	777	873
Investing Cash Flow	-65,513	-58,077	-40,283	-41,373	-26,387
Short-Term Debt Issued	20,257	24,490	5,493	-19,382	3,520
Net Short-Term Debt Issued (Repaid)	20,257	24,490	5,493	-19,382	3,520
Long-Term Debt Issued	-	-	3,800	-	-
Long-Term Debt Repaid	-1	-	-3,800	-	-
Net Long-Term Debt Issued (Repaid)	-1	-	0	-	-
Issuance of Common Stock	397	193	805	368	334
Repurchase of Common Stock	-	-1,389	-	-	-
Net Common Stock Issued (Repurchased)	397	-1,196	805	368	334
Common Dividends Paid	-6,659	-6,662	-6,648	-4,979	-4,146
Other Financing Activities	-5,704	2,279	-3,413	-2,868	-2,130
Financing Cash Flow	8,290	18,911	-3,763	-26,861	-2,422
Effect of Exchange Rate Changes on Cash and Cash Equivalents	1,243	224	-59	286	733
Net Cash Flow	-468	7,262	1,387	-9,359	-701
Free Cash Flow	33,429	18,924	29,030	47,552	13,448
Free Cash Flow Growth	76.65%	-34.81%	-38.95%	253.60%	-48.20%
FCF Margin	9.95%	5.81%	10.40%	19.34%	6.27%
Free Cash Flow Per Share	40.11	22.69	34.83	57.16	16.17
Levered Free Cash Flow	41,945	30,889	27,440	14,181	15,329
Unlevered Free Cash Flow	4,159	-3,963	11,360	22,337	5,720

SEC Filings: 10-K · 10-Q